Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies

This publication has 24 references indexed in Scilit:

• Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-β-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o−)
  European Journal of Pharmaceutical Sciences, 2003
• Nicotine and Cotinine Modulate Cerebral Microvascular Permeability and Protein Expression of ZO-1 through Nicotinic Acetylcholine Receptors Expressed on Brain Endothelial Cells
  Journal of Pharmaceutical Sciences, 2002
• Nasal administration of low molecular weight heparin
  Journal of Pharmaceutical Sciences, 2002
• Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development
  Advanced Drug Delivery Reviews, 1999
• Efficacy, Safety and Mechanism of Cyclodextrins as Absorption Enhancers in Nasal Delivery of Peptide and Protein Drugs
  Journal of Drug Targeting, 1998
• Optimization of systemic nasal drug delivery with pharmaceutical excipients
  Advanced Drug Delivery Reviews, 1998
• Improvement of Nasal Bioavailability of Luteinizing Hormone-Releasing Hormone Agonist, Buserelin, by Cyclodextrin Derivatives in Rats
  Journal of Pharmaceutical Sciences, 1995
• Abaorption Enhancement to Polypeptide Drugs by Cyclodextrins. Part II. Enhancing Effect of Cyclodextrins on Nasal Absorption of Insulin and Its Duration in Rabbits.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
• Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
• Human Nasal and Bronchial Epithelial Cells in Culture: An Overview of Their Characteristics and Function
  Allergy and Asthma Proceedings, 1991